$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
2 Stocks That Wall Street Hates but You'll Probably Like
06:08am, Monday, 01'st Feb 2021
Analysts' pessimism about these stocks appears to be off-base.
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
07:00pm, Sunday, 31'st Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics
Should You Buy Illumina Stock After A 10% Move In 5 Days?
09:30am, Tuesday, 26'th Jan 2021
Illumina, best known for its genetic variation and biological function systems, has gained 9.5% over the last 5 trading days, after a UK court announced a judgment in Illumina's favor in a patent infr
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
10:00am, Monday, 25'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Q4&FY 2020 Earnings Date Announcement
Bear of the Day: Illumina (ILMN)
06:46am, Monday, 25'th Jan 2021
Bear of the Day: Illumina (ILMN)
'Chances are high' the South African Covid-19 variant is in the U.S.: Illumina CEO
09:54am, Friday, 22'nd Jan 2021
The CEO of the largest maker of genome sequencing equipment, Francis deSouza, told CNBC's "Squawk Box" Friday that the United States only sequences 0.3% of positive cases of Covid-19. He added that th
Illumina (ILMN) is in Overbought Territory: What's Next?
09:02am, Friday, 22'nd Jan 2021
Illumina (ILMN) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Illumina Wins Patent Infringement Suit against BGI in the UK
04:05pm, Wednesday, 20'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement su
Final Trades: ILMN, EQIX, BFT & XLF
05:54pm, Friday, 15'th Jan 2021
The Fast Money traders offer their final trades of the week.
3 Top Biotech Picks for January
08:09am, Wednesday, 13'th Jan 2021
Buy these three biotech stocks before they take off.
Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm
09:47am, Tuesday, 12'th Jan 2021
Myriad Genetics (MYGN) partners with Illumina to expand the access as well as extend the reach of myChoice CDx through its services offering in the international market.
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at J.P. Morgan 39th Annual Healthcare Conference (Transcript)
11:11pm, Monday, 11'th Jan 2021
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at J.P. Morgan 39th Annual Healthcare Conference (Transcript)
Illumina CEO on 2021 outlook and tracking new coronavirus strains
03:52pm, Monday, 11'th Jan 2021
Illumina CEO Francis Desouza joins 'Closing Bell' to discuss the company's guidance, tracking the new covid strains and the company's 2020 outlook.
Illumina CEO Says Business Is Bouncing Back
03:42pm, Monday, 11'th Jan 2021
Gene sequencer sees new opportunities.
New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
02:10pm, Monday, 11'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinfo
Sign In
Buy ILMN